Home LiteratureArticle Details
PMID: 8849266 Published · ppublish English Comparative Study Journal Article

Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Antimicrobial agents and chemotherapy ·Vol. 40 ·No. 4 ·1996-04-00 ·Pages 992-8

Wondrack L, Massa M, Yang BV, Sutcliffe J

Abstract

Searching through a collection of 124 Staphylococcus aureus clinical strains, we found one isolate, strain 01A1032, that inactivates 14- and 16-membered macrolides. The products of inactivation were purified from supernatant fluids of cultures exposed to erythromycin for 3 h and were found to be identical to products of inactivation from Escherichia coli strains that encode either an EreA or EreB esterase. Further, strain 01A1032 was shown to be resistant to azithromycin, a 15-membered macrolide, by an alternate mechanism, efflux. Thus, strain 01A1032 harbors determinants encoding an esterase activity that hydrolyzes 14- and 16-membered macrolides and a macrolide efflux system.

MeSH Terms
Anti-Bacterial Agents/metabolism Azithromycin/metabolism Base Sequence Drug Resistance, Microbial Erythromycin/metabolism Escherichia coli/metabolism Molecular Sequence Data Staphylococcus aureus/metabolism
Chemicals
Anti-Bacterial Agents Erythromycin Azithromycin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wondrack L
Department of Infectious Diseases, Central Research Division, Pfizer, Inc., Groton, Connecticut 06340, USA.
Massa M
Yang B V
Sutcliffe J
References (43)
43 references, click to expand
  1. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact.
    Gene. 1995 Feb 3;153(1):93-8 PMID: 7883194
  2. Quantitative or semi-quantitative PCR: reality versus myth.
    PCR Methods Appl. 1992 Aug;2(1):1-9 PMID: 1490169
  3. Insights into erythromycin action from studies of its activity as inducer of resistance.
    Antimicrob Agents Chemother. 1995 Apr;39(4):797-805 PMID: 7785974
  4. Erythromycin resistance by ribosome modification.
    Antimicrob Agents Chemother. 1995 Mar;39(3):577-85 PMID: 7793855
  5. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2'-phosphotransferase I in Escherichia coli.
    Antimicrob Agents Chemother. 1995 Oct;39(10):2359-63 PMID: 8619599
  6. A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary.
    Biol Pharm Bull. 1995 Nov;18(11):1482-6 PMID: 8593463
  7. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus.
    Proc Natl Acad Sci U S A. 1971 Apr;68(4):856-60 PMID: 5279527
  8. Acid degradation of erythromycin A and erythromycin B.
    Experientia. 1971 Apr 15;27(4):362 PMID: 5581079
  9. Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol. lincomycin and erythromycin sites.
    Eur J Biochem. 1971 Nov 11;23(1):185-93 PMID: 4942548
  10. Plasmid-mediated pristinamycin resistance. PAC IIA: a new enzyme which modifies pristinamycin IIA.
    J Antibiot (Tokyo). 1977 Aug;30(8):665-9 PMID: 908665
  11. Plasmid mediated pristinamycin resistance: PH 1A, a pristinamycin 1A hydrolase.
    Ann Microbiol (Paris). 1977 Nov-Dec;128B(4):471-4 PMID: 416739
  12. Two new types of resistance to lincomycin in pathogenic staphylococci from animals.
    Ann Microbiol (Paris). 1980 Nov-Dec;131B(3):261-6 PMID: 7469255
  13. Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics.
    CRC Crit Rev Biochem. 1984;16(2):103-32 PMID: 6203682
  14. Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.
    J Antibiot (Tokyo). 1984 Dec;37(12):1692-6 PMID: 6396291
  15. Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli.
    Gene. 1985;35(3):271-8 PMID: 3899861
  16. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review.
    J Antimicrob Chemother. 1985 Jul;16 Suppl A:63-90 PMID: 3932311
  17. Plasmid-mediated high-level resistance to erythromycin in Escherichia coli.
    Antimicrob Agents Chemother. 1986 Mar;29(3):515-8 PMID: 3521489
  18. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci.
    J Antimicrob Chemother. 1993 Feb;31(2):211-7 PMID: 8463168
  19. An increase of 63 kDa-protein present in the cell membranes of Staphylococcus aureus that bears a plasmid mediating inducible resistance to partial macrolide and streptogramin B antibiotics.
    Biol Pharm Bull. 1993 Dec;16(12):1288-90 PMID: 8130780
  20. Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria.
    Antimicrob Agents Chemother. 1994 Jul;38(7):1447-51 PMID: 7979269
  21. Application of nuclear magnetic resonance spectrometry to measure the activity of bacterial macrolide esterase.
    Microbios. 1994;79(321):231-9 PMID: 7837995
  22. Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II.
    Nucleic Acids Res. 1986 Jun 25;14(12):4987-99 PMID: 3523438
  23. Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 1986 Nov;30(5):653-8 PMID: 3800341
  24. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin.
    Antimicrob Agents Chemother. 1987 Mar;31(3):404-9 PMID: 3579257
  25. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci.
    Antimicrob Agents Chemother. 1987 Jun;31(6):883-8 PMID: 3113328
  26. Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp.
    Antimicrob Agents Chemother. 1987 Dec;31(12):1887-91 PMID: 3439797
  27. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides.
    J Antibiot (Tokyo). 1988 Aug;41(8):1029-47 PMID: 3139603
  28. Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes.
    J Biol Chem. 1988 Nov 5;263(31):15880-7 PMID: 2846528
  29. Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin.
    Antimicrob Agents Chemother. 1989 Aug;33(8):1354-7 PMID: 2478074
  30. Microbial glycosylation of erythromycin A.
    Antimicrob Agents Chemother. 1989 Dec;33(12):2089-91 PMID: 2619274
  31. Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis.
    J Antimicrob Chemother. 1989 Dec;24(6):851-62 PMID: 2559912
  32. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum beta-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae.
    Plasmid. 1990 Jan;23(1):27-34 PMID: 2161546
  33. Binding protein-dependent transport systems.
    J Bioenerg Biomembr. 1990 Aug;22(4):571-92 PMID: 2229036
  34. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family.
    Mol Microbiol. 1990 Jul;4(7):1207-14 PMID: 2233255
  35. Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus.
    Microbiol Immunol. 1990;34(9):723-35 PMID: 2126591
  36. Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes.
    Antimicrob Agents Chemother. 1990 Oct;34(10):2024-6 PMID: 2291670
  37. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.
    Antimicrob Agents Chemother. 1991 Jul;35(7):1267-72 PMID: 1929280
  38. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.
    Antimicrob Agents Chemother. 1991 Jul;35(7):1273-6 PMID: 1929281
  39. Cloning and characterization of two genes from Streptomyces lividans that confer inducible resistance to lincomycin and macrolide antibiotics.
    Gene. 1991 Dec 1;108(1):55-62 PMID: 1761231
  40. Sequence similarity between macrolide-resistance determinants and ATP-binding transport proteins.
    Gene. 1992 Jun 15;115(1-2):93-6 PMID: 1612454
  41. Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus.
    FEMS Microbiol Lett. 1992 Oct 1;76(1-2):141-7 PMID: 1426997
  42. Purification and characterization of macrolide 2'-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics.
    FEMS Microbiol Lett. 1992 Oct 1;76(1-2):89-94 PMID: 1330822
  43. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988.
    Antimicrob Agents Chemother. 1995 Feb;39(2):369-73 PMID: 7726500
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1996-04-00
Pages
992-8
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC163245
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]